Get more information on Clinical Documentation Improvement Market - Request Sample Report
The Clinical Documentation Improvement Market Size was assessed to be worth USD 4.3 billion in 2023 and is expected to increase to USD 7.95 billion by 2031, extending at a CAGR of 8% from 2024 to 2031.
The practice of assessing the accuracy and completeness of medical record documentation is known as clinical documentation improvement (CDI). A CDI evaluation includes the disease process, diagnostic results, and any possible gaps in the record. The enhancement of clinical documentation is fascinating because it provides a thorough account of test results, admissions criteria, and patient evaluation. It carries out an accurate portrayal of a patient's clinical record status, which converts into coded data, and facilitates clinical documentation and coding for a healthy patient.
Clinical documentation improvement guarantees the highest level of accuracy for all documents and offers many advantages, such as guaranteed timely reimbursements, assistance in determining the proper consistent regulatory compliance risk adjustment scores, and a smooth transition to the pay-for-quality or value model for providers. Worldwide health organisations are aware that organizing complex data is crucial to delivering a satisfying patient experience. For patients to experience good health, clinical documentation must be appropriately documented.
If a patient's information is not accurately recorded, detailed, and described well, errors may occur that have serious consequences for both patients and doctors. Contrarily, clinical documentation improvement (CDI) services can assist in minimizing documentation errors. It is crucial to offer proper billing procedures and have satisfying medical interactions. Major issues for healthcare providers include inconsistent billing practices and poor patient payment collections. Clinical documentation improvement (CDI) evaluates the medical coding, billing, and payment collection procedures used by a healthcare organisation and offer suggestions for how to enhance the patient experience overall.
DRIVERS
More money being spent on healthcare
Medical Coding and Billing Errors That Caused Revenue Losses
Decreased reimbursements
Expanding Need to Manage Expanding Unstructured Healthcare Data
RESTRAINTS
Infrastructure Shortages in Developing Nations
OPPORTUNITIES
Growing Application of NLP in Documentation
CHALLENGES
Concerns about Data Security
Lack of Willingness to Change from Traditional Approaches
Lack of Highly Qualified IT Professionals
The COVID-19 outbreak created a challenging obstacle for the global healthcare systems. Being overloaded, the hospitals and health systems made an effort to ramp up for tackling COVID-19's issues. The COVID-19 has an impact on nearly 219 nations and territories worldwide. To reduce the spread of the virus, healthcare organisations worked extremely hard to increase testing and give access to appropriate treatment choices. To ensure the security of hospital staff and other patients, some of the health systems' activities include the construction of test tents, expanding the number of available hospital beds, and creating COVID-19 isolation and treatment facilities. Hospitals and healthcare systems are under extreme financial strain as a result of the abrupt rise in inpatient volume.
Budgets for the adoption or improvement of digital health solutions have been cut due to these financial difficulties, which has had a detrimental effect on the market's expansion.
Additionally anticipated to have a favourable effect on business expansion is the COVID-19 pandemic. For instance, the previously postponed elective procedures are now being performed via outpatient surgery clinics following their reopening. Because of the COVID-19 pandemic's safety concerns, doctors and patients preferred outpatient surgery centres. As a result, outpatient surgery facilities' cash flows are continually increasing and calling for mid-revenue cycle management solutions. The usage of outsourced mid-revenue cycle solutions is therefore anticipated to rise quickly as a result of changes in coding methods, which will also positively affect market growth.
By Product & Service
Solutions and consulting services make up the segments of the global mid-revenue cycle management/clinical documentation enhancement market. The benefits that mid-revenue cycle solutions provide when they are connected with EHRs/EMRs, Speech and Voice Recognition software, CDI, encoder systems, transcription systems, and other hospital information management systems are the primary cause of the solutions segment's sizable market share. Furthermore, these solutions also get rid of the extra administrative effort that comes with having to insert particular codes into every record. Additionally, they enhance the entire mid-revenue cycle process by lowering the likelihood of charge capture, data documentation, and coding errors.
By End User
A large part of the market has been taken over by the healthcare sector. Due to the great need for health care providers for these solutions to increase data accuracy in clinical records, increase hospital revenue by reducing coding errors, and shorten claims repayment cycle, the market for centralized healthcare revenue management solutions has expanded. Other key drivers driving the increase in demand for these solutions are loss of revenue resulting from medical billing errors and writing codes, declining reimbursement rates, and the need to reduce rising health care costs.
A significant portion of the market came from North America. North America's market is well-established, with the US leading the market there. The US healthcare delivery system is largely influenced by the healthcare insurance sector, which administers programmes like Medicare and Medicaid. The adoption of ICD-10 coding standards has more recently raised the demand for sophisticated computer-assisted coding systems in the nation. Better insights into health issues and care management, more accurate predictive analytics, and ultimately better health outcomes are all made possible by the increased data that ICD-10 provides. The downward trend in US reimbursement rates is another factor promoting market expansion.
Need any customization research on Clinical Documentation Improvement Market - Enquiry Now
KEY PLAYERS:
Some of the major key players are as follows: 3M Company, Chartwise, Dolbey Systems, Cerner, Epic Systems, Craneware, eZDI Inc., Flash Code, Iodine Software, M*Modal, Nuance, Optum, nThrive, Streamline Health, Vitalware, TruCode., and other players.
Report Attributes | Details |
---|---|
Market Size in 2023 | US$ 4.3 Billion |
Market Size by 2031 | US$ 7.95 Billion |
CAGR | CAGR of 8% From 2024 to 2031 |
Base Year | 2023 |
Forecast Period | 2024-2031 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Product & Service (Solutions, Consulting Service) • By End User (Healthcare Providers, Healthcare Payers) |
Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
Company Profiles | 3M Company, Chartwise, Dolbey Systems, Cerner, Epic Systems, Craneware, eZDI Inc., Flash Code, Iodine Software, M*Modal, Nuance, Optum, nThrive, Streamline Health, Vitalware, TruCode., and other players. |
DRIVERS | • More money being spent on healthcare • Medical Coding and Billing Errors That Caused Revenue Losses • Decreased reimbursements |
RESTRAINTS | • Infrastructure Shortages in Developing Nations |
Ans:- The Clinical Documentation Improvement market is expected to grow at a CAGR of 8% over the forecast period 2024-2031.
Ans: The Clinical Documentation Improvement Market size was valued at USD 4.3 billion in 2023.
North America's market is well-established, with the US leading the market there. The US healthcare delivery system is largely influenced by the healthcare insurance sector, which administers programmes like Medicare and Medicaid
Clinical Documentation Improvement Market is divided into two segments By Product & Service, and By End User
Infrastructure Shortages in Developing Nations are the restraints of Clinical Documentation Improvement Market
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Clinical Documentation Improvement Market Segmentation, By Product & Service
8.1 Solutions
8.2 Consulting Service
9. Clinical Documentation Improvement Market Segmentation, By End User
9.1 Healthcare Providers
9.2 Healthcare Payers
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11.Company Profiles
11.1 3M Company
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Chartwise
11.3 Dolbey Systems
11.4 Cerner
11.5 Epic Systems
11.6 Craneware
11.7 eZDI Inc.
11.8 Flash Code
11.9 Iodine Software
11.10 M*Modal
12.Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share Analysis
12.3 Recent Developments
13.Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product & Service
Solutions
Consulting Service
By End User
Healthcare Providers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Sanger Sequencing Market Size was valued at USD 2,901.15 Million in 2023, and is expected to reach USD 12,356.57 Million by 2032, and grow at a CAGR of 18.63% Over the Forecast Period of 2024-2032.
The Recombinant Proteins Market size was USD 2.5 billion in 2023 and is expected to reach USD 5.0 billion by 2032 with a growing CAGR of 7.6% by 2023-2032.
The Infusion Pump Rental Market Size was valued at USD 379.65 Million in 2023, and is expected to reach USD 567.32 Million by 2032, and grow at a CAGR of 5.03%.
The Tuberculosis (TB) Diagnostics Market size was valued at USD 2.39 billion in 2023 and is expected to reach USD 3.80 billion By 2032 with an emerging CAGR of 5.3% over the forecast period of 2024-2032.
The Tissue Diagnostics Market Size was valued at USD 5.5 billion in 2023 and is expected to reach USD 9.59 billion by 2031 and grow at a CAGR of 7.2% over the forecast period 2024-2031.
The Antidepressants Market Size was valued at USD 19.92 Billion in 2023, and is expected to reach USD 37.44 Billion by 2032, and grow at a CAGR of 7.66%.
Hi! Click one of our member below to chat on Phone